outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,23992.269476,3350.1045484,171824.18826,0,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,708,0.1883050074,0.0546660296,0.6486437023,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2188,1410,1.4480993882,0.7213477437,2.9070470608,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.3044468583,0.0341067471,2.7175822169,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.3184390394,0.1139437085,0.8899431405,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2188,4220,1.1172570148,0.7016362014,1.779074732,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,14669.874229,2034.0439991,105801.64932,0,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,708,0.1916086721,0.0511837764,0.7172953187,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2188,1410,1.6936685185,0.7853061611,3.6527321353,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.2507676568,0.0278872346,2.2549535133,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2327866555,0.0733590303,0.7386906125,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2188,4220,1.3375754642,0.7638563239,2.3422050278,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,14514.490676,1999.5326875,105359.83777,0,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,708,0.2101750166,0.0559538122,0.7894643072,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2188,1410,2.0730367235,0.9392326775,4.5755235739,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.246880847,0.0274114198,2.2235313988,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2278014988,0.0713725679,0.7270793856,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2188,4220,1.3125863516,0.7398170406,2.3287959536,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,14713.442595,2035.5656228,106351.46839,0,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,708,0.1785834007,0.0478528181,0.6664608743,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2188,1410,1.5453081131,0.7236304605,3.2999953634,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,0.2451944661,0.0272464066,2.206541479,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2336595381,0.0736693428,0.7411058343,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2188,4220,1.3419993695,0.7671311208,2.3476590362,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,14606.715523,2024.9461312,105363.85886,0,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,708,0.1901968583,0.0508075656,0.7119972083,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2188,1410,1.6501889362,0.7713746363,3.5302217587,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.2512088826,0.0279358743,2.2589557093,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2334612291,0.073568322,0.7408643292,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2188,4220,1.3257836087,0.7588259425,2.3163443402,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,14381.768569,1971.1177782,104932.98242,0,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,708,0.1986634397,0.05284933,0.7467864262,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2188,1410,1.8649740191,0.8548986459,4.06846836,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.2372685296,0.0263482307,2.1366275334,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.2278185896,0.0714881429,0.7260128413,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2188,4220,1.3054485071,0.7404955864,2.3014260124,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.1047187217,0.2422204167,5.0384004408,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6216096651,0.316314069,1.2215662015,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2197,1427,0.9366062011,0.6640624122,1.3210071221,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.2041457036,0.5018880703,2.8890243887,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2589063386,0.7489753767,2.1160177205,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2197,4262,0.7649826855,0.6070408651,0.9640183105,1,1
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.8008790544,0.3696813837,8.7728663419,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6765170357,0.315020392,1.4528434069,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2197,1427,1.2450827474,0.817335713,1.8966882557,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,2.3383514721,0.8852674231,6.1765376927,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2969110734,0.6883785463,2.4433915632,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2197,4262,1.0064537591,0.7248218673,1.3975146376,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.9704262741,0.4059884309,9.5632766992,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.7263751213,0.3362533568,1.569116876,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2197,1427,1.33249566,0.8775186433,2.0233697567,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2.2855926567,0.8647025266,6.0413074231,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2757720349,0.6749480016,2.4114365567,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2197,4262,0.9839659087,0.7101382185,1.3633809367,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.7895835591,0.367680114,8.7103141911,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.6255778922,0.2916246966,1.3419566444,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2197,1427,1.1323002075,0.7469135516,1.7165356782,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,2.2907911868,0.8662125599,6.0582407884,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.3043177034,0.6924576779,2.4568211541,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.0128237149,0.7292425147,1.4066813944,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1.8197625343,0.3734930629,8.8663914016,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6853615562,0.3191735829,1.4716771306,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2197,1427,1.2886301285,0.8326428822,1.9943335175,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.3317058945,0.8826820816,6.1594683881,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.2917121136,0.6857244807,2.433222426,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.0189858265,0.729494574,1.4233582424,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,1.9921435542,0.4115073559,9.6441433766,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6883225672,0.318917113,1.4856147168,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2197,1427,1.2546555286,0.820374237,1.9188321919,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.222874788,0.8399074003,5.8829965317,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.28007906,0.6778333862,2.4174117608,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.0034208778,0.7217598897,1.3949977995,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,530,136,0.7522624165,0.2083917831,2.7155520952,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2791,683,0.6505849306,0.3665440996,1.1547335025,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2111,1337,0.6800505183,0.5211334862,0.887428499,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,530,658,0.3864080647,0.1901294855,0.7853131883,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.5921075968,0.416339715,0.8420801415,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2111,4102,0.5632539962,0.460991234,0.6882019458,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,MPCD,530,136,0.8844342051,0.2311435074,3.3841481079,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2791,683,0.8699352436,0.4178222272,1.8112663203,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs DMARD,Medicare,2111,1337,0.9216620935,0.6598747141,1.2873065091,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,530,658,0.3792120464,0.1724260331,0.8339910951,1,1
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.72636633,0.460797839,1.1449881068,1,0
Cancer,Solid Cancer,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2111,4102,0.7626606949,0.5740349867,1.0132680917,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,530,136,0.8931599291,0.2324211708,3.4322805287,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2791,683,0.8769050464,0.4217375772,1.8233197656,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2111,1337,0.9491088956,0.6810500914,1.3226746566,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,530,658,0.3801136881,0.172832078,0.8359930492,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7288023067,0.4612641591,1.1515154427,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2111,4102,0.7622924757,0.5715910858,1.0166180561,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,530,136,0.8847191786,0.2310852963,3.3871822989,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2791,683,0.8391151193,0.4030720772,1.7468691663,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2111,1337,0.8773846663,0.6285119774,1.2248037911,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,530,658,0.3751057899,0.1703954104,0.8257520158,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7277837571,0.4618705306,1.146791497,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2111,4102,0.7644168191,0.575452989,1.0154314679,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,530,136,0.8769470182,0.2291692458,3.3557560049,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2791,683,0.8670257606,0.4165907856,1.8044894306,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2111,1337,0.8987521936,0.6422357755,1.2577242444,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,530,658,0.3798697372,0.1727164532,0.8354792759,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7290686735,0.4625204395,1.1492273322,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2111,4102,0.7573926195,0.5699124135,1.0065469124,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,530,136,0.8988244352,0.2335728839,3.4588148755,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2791,683,0.8503718257,0.4089869709,1.7681058158,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2111,1337,0.885015747,0.6319212017,1.2394787046,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,530,658,0.3754238396,0.170559404,0.8263575976,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2791,2616,0.7305285207,0.4625479168,1.1537656967,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2111,4102,0.7567819534,0.5676103631,1.009000121,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,533,139,1.1181909602,0.1307606712,9.5621337202,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2801,705,0.5903169186,0.2361192234,1.4758394479,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2147,1377,1.0010858872,0.7077091775,1.4160802001,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,533,662,0.5442658754,0.189060323,1.5668297738,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.7838273838,0.4186556697,1.4675195205,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2147,4186,0.7363824025,0.5761292532,0.9412107435,1,1
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,MPCD,533,139,4.0879034159,0.412312965,40.529781398,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2801,705,1.1315696941,0.4099669186,3.1233007214,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs DMARD,Medicare,2147,1377,1.4422761332,0.958692465,2.1697890827,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,533,662,1.6849557841,0.4355309269,6.5186553209,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8323388192,0.3739205761,1.8527675504,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2147,4186,1.0707712907,0.7712542283,1.4866059917,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,533,139,4.056356863,0.4102094558,40.111291357,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2801,705,1.1340230833,0.4110461916,3.1286224751,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2147,1377,1.4730398079,0.9793435569,2.2156129588,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,533,662,1.6951485899,0.4371434754,6.5734224657,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8429023675,0.3773361711,1.8828950299,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2147,4186,1.0752809857,0.7700655604,1.5014685213,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,533,139,4.083382981,0.4124960211,40.422248259,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2801,705,1.105605271,0.4012504159,3.0463844192,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2147,1377,1.3955805532,0.9252701707,2.1049474435,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,533,662,1.6696581677,0.4319659234,6.4536535081,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8338693459,0.3747250745,1.8555952973,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2147,4186,1.071761065,0.7721205738,1.487684462,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,533,139,4.0923571889,0.4127769134,40.572490412,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2801,705,1.132694663,0.4103894104,3.1262921675,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2147,1377,1.4474020961,0.96346656,2.1744115622,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,533,662,1.6845183523,0.4354001295,6.517228377,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8320040365,0.3735587956,1.8530703197,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2147,4186,1.0719528147,0.7729343572,1.4866499672,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,533,139,4.0853145792,0.4136002924,40.352474401,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2801,705,1.1129306929,0.4039757452,3.0660621136,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2147,1377,1.4335126859,0.9497880044,2.1635971513,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,533,662,1.6769903934,0.4327993615,6.4979226629,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2801,2643,0.8424666122,0.3772078625,1.8815885436,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2147,4186,1.0767520938,0.772337032,1.5011517299,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,13671.469698,3391.4350759,55112.092524,0,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2805,704,1.0171495551,0.3504873625,2.9518702476,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2158,1391,0.7200423907,0.5090911976,1.0184050457,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.265454482,0.0576419016,1.2224801752,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.5251289838,0.3075272283,0.8967025496,1,1
Cardiac disease,Conduction Block,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2158,4188,0.5908500105,0.4548429496,0.7675258795,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,7393.8457136,1741.921234,31384.286138,0,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2805,704,1.6595285946,0.4981549247,5.528471204,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs DMARD,Medicare,2158,1391,0.8412054999,0.5556268179,1.2735646848,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.1818500528,0.0376556611,0.8782063775,1,1
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9742217348,0.4572527188,2.0756748934,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2158,4188,0.6774180079,0.4776223431,0.9607908091,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,7849.3139576,1842.8408843,33433.016453,0,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2805,704,1.7311002058,0.5225393981,5.7348937395,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2158,1391,0.8858677035,0.5831456224,1.3457386251,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,0.179477407,0.0371719411,0.8665713607,1,1
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9609750405,0.4482380606,2.0602289488,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2158,4188,0.6681421256,0.473033521,0.9437257195,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,7397.8096059,1738.7684761,31474.91326,0,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2805,704,1.5938309735,0.4776681882,5.3181208947,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2158,1391,0.7987084659,0.5225290285,1.2208608111,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,0.1794718929,0.0370995322,0.8682093395,1,1
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.976382502,0.4585461245,2.0790117707,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2158,4188,0.6786936036,0.4785822644,0.9624782232,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,7496.5572558,1766.2338367,31818.1939,0,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2805,704,1.6740890571,0.5015075203,5.5882993928,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2158,1391,0.8633508486,0.5717632717,1.3036421272,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.1814957519,0.0375817937,0.8765070722,1,1
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9711936366,0.4567804713,2.0649242666,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2158,4188,0.6833348179,0.4824670747,0.9678307555,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,7996.2151728,1874.7052194,34106.405865,0,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2805,704,1.6859705278,0.5071878627,5.6044255585,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2158,1391,0.8614729998,0.5642783132,1.3151944916,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,0.1764188095,0.0364848483,0.8530553849,1,1
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2805,2645,0.9610557573,0.4493519917,2.0554669519,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2158,4188,0.6748341414,0.478719393,0.9512903072,1,1
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,426128.10365,135482.34501,1340286.52,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.4453974659,0.1807712026,11.557005784,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2185,1412,0.7785624228,0.4791710751,1.2650167711,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,419445.65015,135253.80971,1300774.1062,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.9167943428,0.3326833981,2.5264617108,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2185,4239,0.7465672547,0.5151199953,1.0820054957,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,754357.23627,217729.56549,2613585.5212,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,709,0.6530794706,0.0808035646,5.2783908397,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs DMARD,Medicare,2185,1412,1.0127167555,0.557714792,1.8389241985,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,739181.9304,215020.45253,2541106.7636,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7851372193,0.2743008764,2.2473149235,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2185,4239,1.0211828763,0.6142571035,1.6976840169,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,804246.06762,232834.09808,2777994.0421,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,0.6778910659,0.0829863544,5.5374922873,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2185,1412,1.1137974292,0.6051074316,2.0501230833,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,798423.21943,231245.36883,2756723.91,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.781956628,0.273277511,2.2374917198,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2185,4239,1.010719226,0.6004550917,1.7012985117,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,754309.19118,216519.80289,2627853.6574,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,709,0.6320871032,0.0783767932,5.0976072119,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2185,1412,0.9678226175,0.5221830237,1.7937783812,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,732795.27781,211511.8867,2538812.0146,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7866829157,0.2749352059,2.2509667607,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2185,4239,1.0208626824,0.6139615149,1.697436388,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,765002.64133,220850.76072,2649884.652,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,709,0.6589328214,0.081492741,5.3279894368,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2185,1412,1.0394216105,0.5779793618,1.8692661985,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,744825.93504,216659.99882,2560535.7543,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7823228757,0.2732676591,2.2396689163,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2185,4239,1.0294577452,0.6218269378,1.7043057878,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,819790.33824,236650.72997,2839865.3102,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,709,0.6670045075,0.0817206474,5.4440955531,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2185,1412,1.0936072055,0.5908784855,2.0240654369,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,801200.37747,229968.4724,2791348.0407,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2648,0.7794574173,0.2724763932,2.2297486332,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2185,4239,1.0209433796,0.6102298053,1.7080866508,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,4.7062747572,0.6372644102,34.756408387,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.9042900938,0.6422067568,1.2733291343,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2197,1427,0.8395806517,0.7226570159,0.9754221646,1,1
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.4999158031,0.7927573238,2.8378765466,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1566802428,0.9335358968,1.4331630832,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2197,4262,0.8995477287,0.805179673,1.0049758375,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,13.292373847,1.6937261145,104.31863864,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.771715226,0.5026238659,1.1848708954,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,2197,1427,0.8871372843,0.7407338511,1.0624768397,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,3.7268784365,1.6398362746,8.470127839,1,1
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.150008397,0.8907740702,1.4846854633,1,0
Infection,Hospitalized infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2197,4262,0.9672865911,0.8340538238,1.1218021218,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,14.579459324,1.8609389772,114.22224843,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.8248991633,0.5348896234,1.2721477477,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2197,1427,0.9657388997,0.8068188273,1.1559616494,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,3.6435167192,1.5989366358,8.302526683,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1284722996,0.8724854524,1.4595655749,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2197,4262,0.9346784324,0.8056420991,1.0843819766,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,13.290465275,1.6945167095,104.24002681,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.777212279,0.5052904243,1.1954687792,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2197,1427,0.8947275615,0.7475360046,1.070901474,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,3.7328370252,1.64235509,8.4842019497,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1495884036,0.8904049689,1.4842162204,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2197,4262,0.9670718805,0.8338113067,1.1216302952,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,13.706027423,1.743302045,107.75825581,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.7943815598,0.5156222111,1.2238457711,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2197,1427,0.9639288296,0.801583152,1.1591545882,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.7035827949,1.6293985843,8.4181523485,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1356539042,0.8808630649,1.4641433403,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2197,4262,0.9982551626,0.8596427807,1.1592179824,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,14.782550894,1.8843674388,115.96666681,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.8436796769,0.5446779175,1.3068189005,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2197,1427,1.0418092979,0.8666315103,1.2523968956,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.6338927886,1.5944861228,8.2817759342,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.1191235318,0.8666645992,1.4451236159,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2197,4262,0.9672773173,0.832577761,1.1237693971,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,0.4262156848,0.1076381433,1.6876899248,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6689312242,0.3863280535,1.1582616863,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2197,1427,0.9390475915,0.706830112,1.2475563281,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,3.6367170967,0.7348727975,17.997279647,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,2.1800487119,1.3377507375,3.552689042,1,1
Infection,Opportunistic infection,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2197,4262,1.4098554358,1.1231789127,1.7697023399,1,1
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,0.3692131511,0.0887209907,1.5364836419,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,0.6674195073,0.3635706302,1.2252056731,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs DMARD,Medicare,2197,1427,0.9295972045,0.664237603,1.3009666402,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,2.7537107566,0.5362426079,14.140843751,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.0208388654,0.5109599508,2.0395179455,1,0
Infection,Opportunistic infection,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2197,4262,1.4316591658,1.0722266922,1.9115808083,1,1
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.4153779943,0.0990321992,1.7422502933,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,0.712253448,0.3856169503,1.3155671027,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2197,1427,1.0527303112,0.7398141082,1.4979994244,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2.696895881,0.5235750191,13.891509579,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.0093257411,0.5067640297,2.0102816931,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.3655352964,1.0270541986,1.815567911,1,1
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,0.3730949622,0.0897682094,1.550658655,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,0.6986744742,0.3792514527,1.28713026,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2197,1427,0.9893329685,0.7030329686,1.392224499,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,2.8016882667,0.5455139402,14.389104596,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.0185090519,0.5108249704,2.0307556381,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.4312088898,1.0718801297,1.9109962294,1,1
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,0.3741155751,0.0898635552,1.5574997366,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.6757076736,0.3685076977,1.2389995189,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2197,1427,0.9665127025,0.693840153,1.3463429582,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.7462135531,0.5345722496,14.10789446,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.0143934144,0.5076515722,2.0269689992,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.4492518827,1.0872040361,1.931864627,1,1
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.4172028611,0.0995093062,1.7491653186,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,0.7388893154,0.3995945782,1.3662783485,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2197,1427,1.138013158,0.8002463056,1.6183441756,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2.745551808,0.5326762448,14.151287587,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,1.0075733895,0.507238704,2.0014327124,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2197,4262,1.3783098844,1.0393311948,1.8278467413,1,1
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,515,132,3.0078218826,0.3966728066,22.807191031,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2723,688,1.2576173175,0.6463949094,2.4468034856,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2084,1343,1.4473894693,0.9079384961,2.3073548318,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,657,1.2512798488,0.5798818848,2.7000347846,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2774455286,0.87143568,1.8726190766,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2084,4160,1.0762298393,0.7911628747,1.4640103877,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,515,132,4.3419337695,0.549845441,34.286705779,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2723,688,1.0837875951,0.4667358127,2.5166175796,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,2084,1343,1.4975669911,0.891315423,2.5161764678,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,515,657,1.2370761696,0.5194858433,2.9459078993,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2340218517,0.7881961025,1.9320191073,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2084,4160,1.0411966278,0.7174322041,1.5110701909,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,515,132,4.4291724723,0.5581596498,35.146877414,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2723,688,1.0994478385,0.4708573694,2.5672010853,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2084,1343,1.5571604146,0.9278770496,2.6132218247,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,515,657,1.2373831593,0.5194038576,2.9478354089,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2356585816,0.7883402049,1.9367934309,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2084,4160,1.0389988887,0.7132180352,1.5135886047,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,515,132,4.3524002182,0.5514407346,34.35253595,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2723,688,1.0638226879,0.4596708055,2.4620199887,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2084,1343,1.4624006635,0.8732805184,2.4489447037,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,515,657,1.2317203726,0.5170948735,2.933958842,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2372362276,0.7900225191,1.9376074046,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2084,4160,1.0428121683,0.7184716417,1.5135701329,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,515,132,4.3000781494,0.5445685091,33.954721549,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2723,688,1.078186315,0.464356424,2.5034341507,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2084,1343,1.4522425013,0.8600858704,2.4520903727,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,515,657,1.239843105,0.5206231646,2.9526364356,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2375743815,0.7904147656,1.9377046286,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2084,4160,1.0298414374,0.7081796602,1.4976049804,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,515,132,4.4437926958,0.5597668557,35.277711286,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2723,688,1.0801259069,0.463908501,2.5148751794,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2084,1343,1.4798939308,0.8806677117,2.4868472152,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,515,657,1.2317357848,0.51685661,2.935384813,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2723,2615,1.2400364422,0.7910212777,1.9439304874,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2084,4160,1.0262410996,0.7027836582,1.4985704096,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,526,137,116897.36152,47677.6284,286612.26636,0,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2778,705,1.1279622436,0.5217717063,2.4384204962,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2148,1375,1.1346906796,0.6918207323,1.8610644035,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,657,0.7691968383,0.2517160095,2.3505210391,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.3113581405,0.8525154768,2.0171600627,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2148,4207,1.1159805326,0.7872468852,1.5819847275,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,526,137,22549.960513,8432.7441337,60300.740907,0,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2778,705,0.7550545367,0.3120522098,1.8269614364,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2148,1375,1.2235214845,0.6960880796,2.1505968382,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,526,657,0.4839642716,0.1444497445,1.6214733847,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1759762274,0.7336073665,1.8850956937,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2148,4207,1.1474124407,0.7345109858,1.7924242583,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,526,137,40910.897243,15229.63415,109897.68347,0,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2778,705,0.7721753796,0.3161733009,1.8858480941,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2148,1375,1.3684265212,0.7452446553,2.5127199913,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,526,657,0.4828723885,0.1441414949,1.6176170766,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1840241716,0.7340453774,1.9098454704,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2148,4207,1.1172872534,0.7250798488,1.7216459798,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,526,137,22529.577293,8427.2281535,60231.174922,0,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2778,705,0.7644860409,0.315599824,1.8518353381,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2148,1375,1.2439994031,0.7033250693,2.2003118937,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,526,657,0.4860377901,0.1448985404,1.6303320432,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1743500618,0.7328388394,1.8818572291,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2148,4207,1.1468429483,0.7343613684,1.7910102637,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,526,137,22616.290267,8457.5791878,60477.894924,0,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2778,705,0.7571995763,0.312696296,1.8335720815,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2148,1375,1.2332010317,0.699312917,2.1746842474,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,526,657,0.4836385369,0.1443497321,1.6204133604,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1751244054,0.7329772608,1.8839839132,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2148,4207,1.1507145707,0.7361242227,1.7988051233,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,526,137,40864.563808,15221.381507,109708.3451,0,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2778,705,0.7802831642,0.319545436,1.9053372313,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2148,1375,1.3904113781,0.7509085317,2.574539666,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,526,657,0.4852611678,0.1446309655,1.6281326765,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2778,2637,1.1853126724,0.733504664,1.9154154028,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2148,4207,1.115618752,0.7248693323,1.7170062857,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,2.6976542495,0.6559152744,11.0949367,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,3278476.0777,465455.84779,23092212.598,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2196,1425,5611260.0559,1848006.325,17037950.027,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,6.9359249E-8,1.1384469E-8,4.2256741E-7,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,2651067.0969,376864.8869,18649009.225,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2196,4258,1.2967634835,0.3205756949,5.2455490507,1,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,1.241615681,0.6168915965,2.4989957849,1,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,2744900.8614,352373.91092,21382061.797,0,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2196,1425,5924725.0214,1902616.0376,18449527.328,0,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,4.3509295E-8,1.1761023E-8,1.6096039E-7,0,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,2612431.9974,381302.94456,17898631.622,0,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2196,4258,1.1978509657,0.2924910827,4.9056091649,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,2.6666620004,1.3226153189,5.3765339949,1,1
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,3063136.5949,417156.88206,22492271.379,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2196,1425,5229047.1216,1751102.6718,15614694.809,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,6.841093E-8,1.8006124E-8,2.5991465E-7,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,2653574.9334,378036.59706,18626397.502,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2196,4258,1.3009350342,0.3208585978,5.27469725,1,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,2.6491794212,2.6491794212,2.6491794212,1,1
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,3213782.5469,457038.30881,22598539.464,0,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2196,1425,5097338.2811,1677262.5807,15491228.297,0,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,6.8660934E-8,2.5172955E-8,1.8727733E-7,0,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,2715778.6927,386222.72416,19096374.828,0,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2196,4258,1.2696305026,0.3135797395,5.1405158239,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,536,138,621661.03182,86271.893272,4479586.8484,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,329924.4172,105036.11778,1036311.3504,0,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2194,1422,1.7093606706,0.5530068125,5.2836851843,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,536,662,1.2146591016,0.0759393953,19.428607862,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.8024531146,0.1611603434,3.9955921377,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2194,4258,1.9323283338,0.8703044723,4.2903293139,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,MPCD,536,138,2181187.5371,288354.39501,16499069.043,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,218393.76328,68741.229085,693846.13099,0,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs DMARD,Medicare,2194,1422,2.0115297995,0.609703526,6.6364256752,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,536,662,5.0774212388,0.3139944315,82.104024307,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.6816265178,0.1351900727,3.4367516832,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2194,4258,1.8061422799,0.7392443496,4.4128168677,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,536,138,5009139.14,678496.54348,36980991.524,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2819,710,519958.07309,163048.77855,1658132.0031,0,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2194,1422,1.7541805613,0.5472989818,5.6224285881,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,536,662,5.2215718708,0.3212408303,84.873435237,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.6916968482,0.1367318384,3.4991450096,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2194,4258,1.8975667491,0.7560624956,4.7625157813,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,536,138,2188201.8297,291186.88048,16443828.923,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,228919.50599,72461.920441,723195.57507,0,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2194,1422,2.1392514323,0.6149195364,7.4422691419,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,536,662,5.1440016463,0.3219669277,82.184692462,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.6800942416,0.1348759862,3.4292848597,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2194,4258,1.8068243521,0.7391989484,4.4164216503,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,536,138,2556128.5919,333333.99119,19601341.45,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,225941.87063,70358.517698,725565.72498,0,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2194,1422,2.3022658532,0.6656698675,7.9625476797,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,536,662,5.0245665011,0.3109906849,81.180143823,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.6660955731,0.1321192134,3.3582043158,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2194,4258,1.8962101256,0.7592253536,4.7358966915,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,536,138,5819210.2113,753651.98243,44932154.725,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,567230.50539,177029.02347,1817501.1077,0,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2194,1422,2.0912194161,0.6001173098,7.2872396361,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,536,662,5.2645098368,0.3282225029,84.439864956,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2651,0.6658494596,0.1315504706,3.37023122,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2194,4258,2.0529014578,0.774244893,5.4432446807,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1705897.4958,414826.9881,7015180.6648,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.3890039992,0.0350852075,4.3130459344,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2195,1422,0.941933578,0.3065959327,2.8938376892,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1701054.7911,419521.86624,6897345.8478,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.6940441581,0.152179442,18.857905984,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2195,4259,2.3701970002,0.8701362451,6.4562691781,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1768014.4505,411473.40955,7596785.1741,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.5302593417,0.047415394,5.9300354945,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,2195,1422,0.6936768979,0.1986975116,2.4217094351,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1760273.0955,417288.42515,7425466.8572,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7299120919,0.1549896771,19.308355898,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2195,4259,1.6228944245,0.5044658608,5.2209406381,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,2148058.3697,461242.35182,10003753.431,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2818,710,0.5380713184,0.0495319291,5.8451336067,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2195,1422,0.7264733138,0.2105884057,2.5061373812,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,2038467.735,492013.26815,8445607.0106,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7143065208,0.1500028555,19.591939344,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2195,4259,1.588234875,0.4790300862,5.2658279524,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1799521.3369,416603.93256,7773035.2237,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2818,710,0.50175315,0.0454474273,5.5395043941,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2195,1422,0.6424877129,0.1677733203,2.4604058646,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1741133.668,413663.26206,7328536.8269,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7408105815,0.1559134592,19.436561133,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2195,4259,1.6297056875,0.508478578,5.2233087937,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1852441.821,430991.05716,7961976.5724,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2818,710,0.5413039605,0.0483547557,6.0595896647,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2195,1422,0.7370052298,0.2227134194,2.4389042662,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1846365.7762,437551.39198,7791236.9655,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7216888007,0.1542086551,19.222087916,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2195,4259,1.6542363331,0.5181910512,5.2808666595,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,2357367.0299,505172.67042,11000554.145,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2818,710,0.529481589,0.0490919228,5.7107307554,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2195,1422,0.722351212,0.2050432252,2.5447867047,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,2143589.7252,518489.15818,8862242.9949,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1.7153404034,0.1512867424,19.449111359,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2195,4259,1.6317966928,0.4980579943,5.3462859286,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0115941139,0.8153936563,1.2550044304,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.5604554106,0.0581990142,5.3971750471,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2188,1418,0.6483507746,0.336866862,1.247848258,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,0.9962521511,0.8786100449,1.1296460293,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,823033.65475,265137.04675,2554846.2772,0,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2188,4253,2.388349439,1.2292564809,4.640376627,1,1
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0389696659,0.7923700173,1.3623155129,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2818,710,0.9257445139,0.0926475537,9.2501406811,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs DMARD,Medicare,2188,1418,0.7289965635,0.3364823435,1.5793874473,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.018313121,0.8509079693,1.2186530739,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2818,2651,491694.68087,147660.61668,1637292.7639,0,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2188,4253,2.8252006937,1.2750402466,6.2600055025,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.962939924,0.7157533805,1.2954927248,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2818,710,0.9926802227,0.1001438533,9.8399851001,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2188,1418,0.8417420424,0.397390005,1.7829579431,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,1.0029665272,0.8228601126,1.2224943698,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2818,2651,693680.42003,206723.53945,2327710.3633,0,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2188,4253,2.7116786446,1.2044427167,6.1050649976,1,1
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.0388378443,0.7918173617,1.3629204398,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2818,710,0.9278027891,0.0926707165,9.2889970795,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2188,1418,0.7312928044,0.3467271681,1.5423918716,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.018944385,0.8530939565,1.2170378794,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2818,2651,491569.78604,147571.21893,1637452.4539,0,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2188,4253,2.8249026547,1.2735229513,6.266141494,1,1
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,0.9498919241,0.7195359862,1.2539951924,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2818,710,0.9578492158,0.0958181979,9.5751656799,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2188,1418,0.8026358498,0.3746230544,1.7196600683,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.0486914711,0.87507776,1.256749802,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,627698.7152,188391.15486,2091423.4395,0,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2188,4253,2.9267175143,1.3254248948,6.4625882928,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.9961161312,0.7388514288,1.3429592313,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2818,710,1.0212879305,0.1026308342,10.16292077,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2188,1418,0.9190077677,0.4435597743,1.9040844682,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.0551015544,0.8676340093,1.2830747505,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2818,2651,1014846.2531,302814.27613,3401137.26,0,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2188,4253,2.8339364207,1.2546876258,6.4009522941,1,1
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,534,139,27025.725139,9979.5569409,73188.601823,0,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2804,704,1.0991940922,0.3822283943,3.1610096752,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2134,1372,1.1222103401,0.8032076206,1.5679084898,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,662,0.484920347,0.1523575034,1.5433945664,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2804,2643,0.9324375158,0.5198898726,1.6723536398,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2134,4187,1.0103360241,0.7975510529,1.2798915854,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,MPCD,534,139,21066.351121,6827.6920706,64998.706001,0,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2804,704,1.0034868561,0.31262038,3.2211139609,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs DMARD,Medicare,2134,1372,1.0108998353,0.7067150163,1.4460121173,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,662,0.4014156185,0.1115036074,1.445105702,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.014777979,0.5038507598,2.0438082641,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2134,4187,0.8788390587,0.6719025098,1.1495091622,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,139,23145.911244,7500.1182556,71429.968042,0,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2804,704,1.0780362623,0.3348449435,3.4707472979,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2134,1372,1.0986539992,0.7671156412,1.5734793365,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,662,0.3929115611,0.1090105199,1.4161889606,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2804,2643,0.9999961465,0.4952241902,2.0192719029,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2134,4187,0.8517691675,0.6489134567,1.1180392504,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,534,139,21042.921818,6820.9377104,64918.428729,0,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2804,704,0.9864775563,0.3065172588,3.1748227579,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2134,1372,0.9899717493,0.69146619,1.4173419881,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,534,662,0.3994874426,0.1110028024,1.4377134033,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0157044859,0.5042570916,2.0458921052,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2134,4187,0.8789666473,0.6719841251,1.1497033013,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,534,139,21324.62532,6911.6255438,65793.443548,0,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2804,704,1.0092193689,0.3145399773,3.2381376233,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2134,1372,1.0349215013,0.7216949069,1.4840932139,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,534,662,0.4006510098,0.1112896115,1.4423739058,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2804,2643,1.0129584692,0.5029110038,2.0402911302,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2134,4187,0.8871623867,0.6770459753,1.1624869345,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,534,139,23410.924995,7586.7710278,72240.404659,0,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2804,704,1.0643497955,0.3301614791,3.431170984,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2134,1372,1.0925071922,0.7611519483,1.5681126057,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,534,662,0.3896533412,0.1081588948,1.4037655122,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2804,2643,0.9991939634,0.4948627423,2.01750605,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2134,4187,0.8598434866,0.6540342725,1.1304160232,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0166130828,0.0000521628,19813.027763,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2819,710,2448580.9687,351430.25467,17060422.888,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2195,1424,1.7869584348,0.1827318504,17.474898002,1,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,9.3274397E-8,3.96471E-12,0.0021943882,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2650,2441306.7691,349129.3713,17070974.919,0,0
Neurological Disease,Cauda Equina syndrome,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2195,4257,1.0367617968,0.2539869088,4.2320095486,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0239026318,0.5498606135,1.9066224669,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2819,710,4039859.749,604145.47557,27014133.932,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs DMARD,Medicare,2195,1424,2.0387751556,0.1993660191,20.849110362,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,1.6870628E-7,2.1617598E-8,1.3166038E-6,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2819,2650,4034682.8732,597692.46811,27235855.821,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2195,4257,1.0677606363,0.236308474,4.8246800331,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.0442766355,1.0442766355,1.0442766355,1,1
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2819,710,4404397.748,633625.1083,30615452.685,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2195,1424,2.3016403007,0.2130774057,24.86208266,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,1.7550008E-7,3.1794804E-8,9.6872045E-7,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2819,2650,3999680.059,593848.60802,26938583.94,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2195,4257,1.0608314054,0.2363822392,4.7607776061,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1.0278707852,0.819242774,1.2896279156,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2819,710,4059163.4932,608887.34396,27060520.19,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2195,1424,2.0671885112,0.1994651086,21.423638303,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,1.6817021E-7,2.3336422E-8,1.2118919E-6,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2650,4034484.0346,596811.42819,27273374.23,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2195,4257,1.0722433512,0.2364674426,4.8620046435,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.6055029793,0.0381535107,9.6094396426,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2819,710,8628065.5276,1212691.4238,61387021.702,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2195,1424,1.8518768387,0.1695305018,20.229090283,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,6.4840971E-8,2.1785114E-9,1.9299195E-6,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2819,2650,12029699.296,1774695.6011,81542809.399,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2195,4257,1.1950443025,0.2591189585,5.5114874395,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,537,139,0.9982727469,0.7283243483,1.3682756585,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.8433989316,0.235944549,14.402195918,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2193,1424,1.3097085848,0.5065206537,3.3865086534,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,3.3031014E-6,4.585037E-7,0.0000237958,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.8963004064,0.3649556612,2.2012384076,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2193,4253,1.332482411,0.677051158,2.6224153887,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,MPCD,537,139,1.0024528257,0.7492691358,1.3411891933,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2817,709,1.5792220594,0.2009774278,12.409066731,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs DMARD,Medicare,2193,1424,1.4668776409,0.506082506,4.2517375876,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,537,663,3.6650856E-6,5.1365477E-7,0.0000261515,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.574718054,0.2221362327,1.4869291589,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2193,4253,1.4435887614,0.6276028748,3.3204891114,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,537,139,0.9395033196,0.6695296416,1.3183381776,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2817,709,1.6515237266,0.2069748401,13.178078158,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2193,1424,1.5610010845,0.5334095818,4.5682051257,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,537,663,3.5326839E-6,4.9201609E-7,0.0000253647,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5904099188,0.2271442216,1.53463676,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2193,4253,1.4352265826,0.6151599215,3.3485200699,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,537,139,1.0099539855,0.7531098293,1.3543934936,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2817,709,1.6682487145,0.2107668352,13.204419806,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2193,1424,1.5884136841,0.5200511221,4.8515577116,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,537,663,3.7389743E-6,5.2521876E-7,0.0000266173,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5731614427,0.22134128,1.4841968901,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2193,4253,1.4422733559,0.6279480385,3.3126187288,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,537,139,1.0066750837,0.7542689278,1.3435456333,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2817,709,1.5885608216,0.2020687704,12.488448755,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2193,1424,1.4957482334,0.5241345901,4.2684890865,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.6524411E-6,5.1205581E-7,0.0000260525,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5730346272,0.2214599951,1.4827449255,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2193,4253,1.4525875073,0.6349229696,3.3232542647,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,537,139,0.9433190362,0.6667422706,1.3346248518,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2817,709,1.7187608048,0.2152484415,13.72432099,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2193,1424,1.706323986,0.5650159621,5.1530252952,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,537,663,3.608639E-6,5.0268309E-7,0.0000259055,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2817,2651,0.5916497242,0.2271057016,1.5413501012,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2193,4253,1.4487518415,0.6219631879,3.374607917,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,535,138,33327.040453,12221.42684,90880.683566,0,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2814,708,2.7447224682,0.3632020258,20.741903658,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2158,1394,0.9862573613,0.7005491656,1.3884872477,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,535,662,0.8026784628,0.225935333,2.8516686882,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.5255825387,0.2745925063,1.0059888696,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2158,4190,0.8738567472,0.6814255551,1.1206295522,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,535,138,33930.402999,10720.106863,107393.72867,0,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2814,708,7.9099981359,1.0035926408,62.344090585,1,1
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,2158,1394,1.0438431185,0.7115624369,1.5312900169,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,535,662,0.9296086121,0.2315266638,3.7324952456,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8185758561,0.3760285958,1.7819560522,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2158,4190,0.9018398661,0.6685542938,1.2165281887,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,535,138,35205.697411,11018.657458,112485.67577,0,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2814,708,8.0070926475,1.0161864478,63.092292567,1,1
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2158,1394,1.0710187047,0.7330607429,1.5647831054,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,535,662,0.9257624447,0.2311320949,3.7079926275,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8135633392,0.3736700193,1.7713096387,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2158,4190,0.8858771604,0.6530594306,1.2016951391,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,535,138,33926.372337,10717.062073,107398.71918,0,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2814,708,7.8474498239,0.9957172298,61.847346712,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2158,1394,1.0337236934,0.7011444221,1.5240578699,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,535,662,0.9270472583,0.2309132413,3.7218161,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8188291742,0.3762220042,1.7821424825,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2158,4190,0.9022838983,0.6690158336,1.2168863459,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,535,138,34062.150055,10761.924813,107808.7876,0,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2814,708,7.9345302584,1.0066892143,62.538437414,1,1
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2158,1394,1.0546660864,0.7182483086,1.548657394,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,535,662,0.9288713758,0.2313432294,3.7295322413,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8174378338,0.3754493652,1.7797462831,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2158,4190,0.9042723147,0.6706644117,1.2192512454,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,535,138,35324.913979,11051.944295,112907.69428,0,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2814,708,7.96498653,1.0109594314,62.75327026,1,1
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2158,1394,1.069848526,0.7290197947,1.5700202888,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,535,662,0.9222304211,0.2302922294,3.6931725909,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2814,2648,0.8127907579,0.3733288322,1.7695628066,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2158,4190,0.8888387918,0.6557513989,1.204777297,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,534,138,1.0934917674,0.2402691584,4.9766031281,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2803,705,1.1928347269,0.5389227119,2.640183192,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2136,1369,0.625385871,0.468751768,0.8343594934,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,658,0.6605841254,0.3052622713,1.4294966253,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.1571996766,0.7377214994,1.8151986794,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2136,4158,0.7409850227,0.5879857162,0.9337961599,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,MPCD,534,138,1.5031181614,0.2787455537,8.1054717368,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2803,705,2.0127960287,0.8432370322,4.8045184191,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs DMARD,Medicare,2136,1369,0.652812651,0.4640800765,0.9182991877,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,534,658,1.0614137616,0.3717359082,3.0306439287,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.587720051,0.9353842086,2.6949941397,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2136,4158,0.7774218742,0.5807401183,1.040714687,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,534,138,1.5116942872,0.281646346,8.1137911083,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2803,705,2.0137933507,0.8421621203,4.8154192188,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2136,1369,0.6581888221,0.4694421583,0.9228240749,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,534,658,1.0606376657,0.3709337368,3.0327580001,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5872359635,0.9342050367,2.6967506112,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2136,4158,0.7709548613,0.5736571484,1.0361091113,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,534,138,1.5099631104,0.2794112769,8.159973426,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2803,705,2.0770378939,0.8677748846,4.9714349759,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2136,1369,0.6804715417,0.4822330463,0.9602027954,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,534,658,1.0726271855,0.3748277034,3.0694878433,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5854408573,0.9337738874,2.6918965563,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2136,4158,0.7752942084,0.5789742708,1.0381827653,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,534,138,1.5258197015,0.2828335274,8.2314348751,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2803,705,2.0559326113,0.8611162761,4.908580896,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2136,1369,0.6850737527,0.4835082955,0.9706680341,1,1
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,534,658,1.0570646776,0.3701684596,3.0185870884,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5795642304,0.9310826717,2.679700991,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2136,4158,0.7898287021,0.5888732055,1.0593611204,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,534,138,1.5160356718,0.2815304917,8.1638196415,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2803,705,2.0986557586,0.8755107254,5.030613407,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2136,1369,0.7114258985,0.5028156368,1.0065852612,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,534,658,1.070620896,0.3737133784,3.0671342511,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2803,2640,1.5804288076,0.9305010927,2.6843119642,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2136,4158,0.7847031799,0.582068598,1.0578806048,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,531,137,2.9130977872,0.3851018902,22.036086899,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2749,693,1.2305992079,0.6710360513,2.2567705679,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2119,1365,1.3736428448,0.9442499949,1.9982998943,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,531,659,1.9818843685,0.821223235,4.7829451024,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5665000397,1.0784189823,2.2754814359,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2119,4188,1.5075570873,1.1511783118,1.9742626735,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,MPCD,531,137,3.8732917887,0.4898092444,30.629044779,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2749,693,0.8764332264,0.4423187763,1.7366099782,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2119,1365,1.1896081654,0.7945243066,1.7811507784,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,531,659,1.162981839,0.4217261134,3.2071211978,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5041180927,0.9874486624,2.2911279571,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2119,4188,1.1842684055,0.8677514041,1.6162366889,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,531,137,4.0372754459,0.5087997989,32.035376313,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2749,693,0.9000384333,0.45509747,1.779990518,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2119,1365,1.2440741186,0.8222949867,1.8821960946,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,531,659,1.1546730773,0.4189037414,3.1827596262,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.4919544155,0.9783937161,2.2750840905,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2119,4188,1.1738561755,0.8582322014,1.6055542062,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,531,137,3.8732826498,0.4898233411,30.628018772,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2749,693,0.8767446292,0.4419794333,1.7391785385,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2119,1365,1.1901768458,0.7951628881,1.7814223293,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,531,659,1.1631217712,0.4217974684,3.2073503423,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5040706399,0.9873951043,2.2911076629,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2119,4188,1.1842416088,0.8676926003,1.6162730757,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,531,137,3.8481195071,0.4866319924,30.429614105,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2749,693,0.8700927531,0.4391522544,1.7239155471,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2119,1365,1.165836472,0.7778054568,1.747448115,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,531,659,1.1647138369,0.4223423324,3.2119875699,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.5073583846,0.9895740477,2.2960679949,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2119,4188,1.1760254248,0.8612922778,1.6057682572,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,531,137,4.0266082959,0.5073113631,31.959809199,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2749,693,0.8938333982,0.4515699187,1.7692457152,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2119,1365,1.2196000371,0.8067830144,1.8436484457,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,531,659,1.1555691369,0.4192294695,3.1852246259,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2749,2618,1.4941378168,0.9797446092,2.2786017853,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2119,4188,1.163542986,0.8501796475,1.5924073039,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,519,135,1.8167802801,0.420812883,7.8436063141,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2705,686,0.8728224158,0.5236738713,1.4547584121,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2097,1347,1.0982151279,0.7539931041,1.5995855408,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,519,656,2.2028821899,0.9768501961,4.9676910155,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0702675405,1.3882590671,3.0873255508,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2097,4164,1.9524686882,1.4420900207,2.6434785095,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,MPCD,519,135,4.0480295261,0.8012902995,20.45019521,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2705,686,0.7609710282,0.4150929271,1.3950536569,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2097,1347,0.9769302997,0.6368945572,1.4985099178,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,519,656,3.2943172432,1.1004099027,9.8622577568,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0192184206,1.2866488988,3.1688854929,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2097,4164,1.6715985053,1.1607500703,2.4072723616,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,519,135,4.1021638148,0.8149316809,20.649274481,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2705,686,0.7733120524,0.4237969514,1.4110803024,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2097,1347,1.0140482784,0.6655837354,1.544950479,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,519,656,3.2824158923,1.0937543217,9.8507076743,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0246364253,1.2893210849,3.1793109589,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2097,4164,1.648365325,1.137072629,2.3895643739,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,519,135,4.0665146263,0.8059732231,20.517482134,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2705,686,0.7832066059,0.4274002451,1.4352181463,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2097,1347,1.0200361824,0.6605374839,1.575192686,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,519,656,3.328473733,1.1148217665,9.9376758905,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0126609308,1.2827201247,3.1579796282,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2097,4164,1.669052053,1.1596518356,2.4022164845,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,519,135,4.0276953484,0.7972590268,20.347627651,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2705,686,0.7565891238,0.4125537413,1.3875212968,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2097,1347,0.9611260103,0.6238135791,1.4808321568,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,519,656,3.2981608849,1.1016748419,9.8739344941,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0220236141,1.2884562198,3.1732389762,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2097,4164,1.6619094921,1.1524583939,2.396566483,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,519,135,4.0860840887,0.8123277249,20.553383406,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2705,686,0.7881652596,0.4319592072,1.4381091228,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2097,1347,1.0327794065,0.6704766695,1.5908581926,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,519,656,3.3267916413,1.1116525753,9.9559366569,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2705,2607,2.0259183306,1.2899796437,3.1817130622,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2097,4164,1.6321297325,1.12337326,2.3712932811,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,MPCD,506,130,0.7464388685,0.2771065883,2.0106738989,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Marketscan,2648,666,1.3778854041,0.8415056233,2.2561562685,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs DMARD,Medicare,2059,1309,1.5162574527,1.1042970703,2.0819005362,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,MPCD,506,640,0.6074645062,0.3399876849,1.0853720375,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9054594396,0.7055505254,1.1620100436,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates",TNF vs NSAID or no exposure,Medicare,2059,4090,1.2878558942,1.0422589197,1.5913251237,1,1
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,MPCD,506,130,0.6529724895,0.2008020146,2.1233505696,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Marketscan,2648,666,1.6016667142,0.9348214877,2.7441990766,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs DMARD,Medicare,2059,1309,1.3531361852,0.9465024965,1.9344666733,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,MPCD,506,640,0.5606647105,0.288658668,1.0889848548,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9588560786,0.7213715168,1.2745235403,1,0
Uveitis,Uveitis,"a Weighted, no covariates",TNF vs NSAID or no exposure,Medicare,2059,4090,1.0947626622,0.8391173001,1.4282929054,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,MPCD,506,130,0.6588980597,0.201842117,2.1509220151,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Marketscan,2648,666,1.6172880792,0.9430029193,2.773714352,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs DMARD,Medicare,2059,1309,1.3676514839,0.9571321425,1.954244872,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,MPCD,506,640,0.5612982019,0.2889661776,1.0902856315,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9637358255,0.7241595121,1.282572038,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)",TNF vs NSAID or no exposure,Medicare,2059,4090,1.0938862027,0.8366033628,1.4302919132,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,MPCD,506,130,0.6515371433,0.20053908,2.1167976294,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Marketscan,2648,666,1.5691084177,0.9150696896,2.6906160859,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs DMARD,Medicare,2059,1309,1.3170212474,0.9143585611,1.8970074103,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,MPCD,506,640,0.5570546036,0.2865407279,1.0829519199,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9596979777,0.7221721147,1.2753472332,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)",TNF vs NSAID or no exposure,Medicare,2059,4090,1.0950788268,0.8392536927,1.4288857437,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,MPCD,506,130,0.6468824064,0.1989044151,2.1038087445,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Marketscan,2648,666,1.585430924,0.9254927294,2.715949175,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs DMARD,Medicare,2059,1309,1.3158914453,0.9199795543,1.8821834547,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,MPCD,506,640,0.5616689438,0.2891647963,1.0909765176,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9623233577,0.7238803837,1.2793083851,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)",TNF vs NSAID or no exposure,Medicare,2059,4090,1.0854098382,0.8319794271,1.4160380394,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,MPCD,506,130,0.6578117349,0.2016128226,2.1462735995,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Marketscan,2648,666,1.5783867504,0.9199070652,2.7082135012,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs DMARD,Medicare,2059,1309,1.3014292055,0.9047616444,1.8720046184,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,MPCD,506,640,0.5575895543,0.2868184927,1.0839820966,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Marketscan,2648,2552,0.9660813896,0.7258869073,1.2857557313,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)",TNF vs NSAID or no exposure,Medicare,2059,4090,1.0830597428,0.8281947846,1.4163557031,1,0
